Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

These Multibagger Mid-Cap Stocks Gave Investors Super-Duper Gains In 2013. Do You Have In Portfolio For 2014?



Angel Broking has compiled a list of the best multi-bagger mid-cap stocks of 2013 which delighted investors with gains of as much as 265%. Do you have these stocks in your portfolio and will these stocks give the same or similar gains in 2014?




Stock Price on 1.1.2013 (Rs.) Price on 31.12.2013 (Rs.) Gains (%)
Ajanta Pharma 257 954 265
Ceat 107 313 192
Alembic Pharma 72 196 172
Finolex 62 160 159
PI Industries 112 235 110
PVR Cinemas 589 1742 109
Mindtree 691 1386 101
HCL Tech 622 1187 91
Tech Mah 932 1742 87
Aurobindo 193 349 80
investments, Multibagger, Portfolio, stock picker, Top Picks    , ,

2 Comments
  1. R.Ravi's Gravatar R.Ravi
    January 2, 2014 at 1:45 pm | Permalink

    Another multi bagger stock to be noted is kiri dyes which increases to Rs 56 from Rs 4 in 2 months.

    Reply
  2. Sagar's Gravatar Sagar
    January 2, 2014 at 9:51 pm | Permalink

    The CMP of PVR is ABSOLUTELY wrong!

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap)
    Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap) for Nov '24. The Basket has delivered return of 329% since inception (May’20) vs 162% return delivered by NIFTY Index over the same period due to thematic approach to Top Picks selection Download report
  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!